TR200101336T2 - Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar - Google Patents

Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar

Info

Publication number
TR200101336T2
TR200101336T2 TR2001/01336T TR200101336T TR200101336T2 TR 200101336 T2 TR200101336 T2 TR 200101336T2 TR 2001/01336 T TR2001/01336 T TR 2001/01336T TR 200101336 T TR200101336 T TR 200101336T TR 200101336 T2 TR200101336 T2 TR 200101336T2
Authority
TR
Turkey
Prior art keywords
agonist
beta
combinations
antidiabetic agent
another antidiabetic
Prior art date
Application number
TR2001/01336T
Other languages
English (en)
Inventor
Robert Sanders Arch Jonathan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824791.9A external-priority patent/GB9824791D0/en
Priority claimed from GBGB9824790.1A external-priority patent/GB9824790D0/en
Priority claimed from GBGB9824789.3A external-priority patent/GB9824789D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200101336T2 publication Critical patent/TR200101336T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)

Abstract

Bir memelide, örnegin bir insanda diyabet mellitusun ve diyabet mellitus ile ilgili vakalarin tedavisi için, ihtiyaç duyan memeliye bir beta antagonisti ve baska bir antidiyabetik maddeden, etkili, toksik olmayan ve farmasötik olarak kabul edilebilir bir miktarda verilmesini içeren bir yöntem.
TR2001/01336T 1998-11-11 1999-11-11 Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar TR200101336T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9824791.9A GB9824791D0 (en) 1998-11-11 1998-11-11 Novel methods of treatment
GBGB9824790.1A GB9824790D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824789.3A GB9824789D0 (en) 1998-11-11 1998-11-11 Novel method of treatment

Publications (1)

Publication Number Publication Date
TR200101336T2 true TR200101336T2 (tr) 2001-11-21

Family

ID=27269550

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01336T TR200101336T2 (tr) 1998-11-11 1999-11-11 Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar

Country Status (15)

Country Link
EP (1) EP1128845A1 (tr)
JP (1) JP2002529430A (tr)
KR (1) KR20010075698A (tr)
CN (1) CN1332638A (tr)
AU (1) AU766928B2 (tr)
BR (1) BR9915214A (tr)
CA (1) CA2350062A1 (tr)
CZ (1) CZ20011655A3 (tr)
HK (1) HK1041201A1 (tr)
HU (1) HUP0104388A3 (tr)
IL (1) IL143004A0 (tr)
NO (1) NO20012300L (tr)
PL (1) PL348154A1 (tr)
TR (1) TR200101336T2 (tr)
WO (1) WO2000027434A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007201729B2 (en) * 1999-12-23 2010-02-25 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
KR20020063260A (ko) 1999-12-23 2002-08-01 노파르티스 아게 당 대사 장애를 치료하기 위한 혈당강하제의 용도
JP2003518493A (ja) * 1999-12-24 2003-06-10 スミスクライン ビーチャム パブリック リミテッド カンパニー 新規治療方法
US20030018061A1 (en) * 2000-01-28 2003-01-23 Kohei Ogawa Novel remedies with the use of beta 3 agonist
WO2001083452A1 (en) * 2000-04-28 2001-11-08 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds
WO2001083453A1 (en) * 2000-04-28 2001-11-08 Asahi Kasei Kabushiki Kaisha Novel substituted tricyclic compounds
WO2006132196A1 (ja) * 2005-06-08 2006-12-14 Asahi Kasei Pharma Corporation β３作動薬を含有する新規な医薬
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0514452T4 (da) * 1990-02-09 2000-09-18 Upjohn Co Anvendelse af insulin-sensibiliserende midler til behandling af hypertension
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
ATE251608T1 (de) * 1996-01-10 2003-10-15 Asahi Chemical Ind Neue trizyklische verbindungen und arzneimittelzusammensetzungen die diese enthalten

Also Published As

Publication number Publication date
WO2000027434A1 (en) 2000-05-18
KR20010075698A (ko) 2001-08-09
HUP0104388A2 (hu) 2002-03-28
AU766928B2 (en) 2003-10-23
CA2350062A1 (en) 2000-05-18
IL143004A0 (en) 2002-04-21
HK1041201A1 (zh) 2002-07-05
NO20012300D0 (no) 2001-05-10
CZ20011655A3 (cs) 2002-06-12
JP2002529430A (ja) 2002-09-10
PL348154A1 (en) 2002-05-06
AU1063400A (en) 2000-05-29
HUP0104388A3 (en) 2002-12-28
BR9915214A (pt) 2001-12-18
CN1332638A (zh) 2002-01-23
EP1128845A1 (en) 2001-09-05
NO20012300L (no) 2001-07-03

Similar Documents

Publication Publication Date Title
TR199903057T2 (tr) Diabetin tiazolidinedion ve metformin ile tedavisi.
MXPA02012763A (es) Combinaciones de inhibidores de dipeptidil peptidasa iv y otros agentes antidiabeticos para el tratamiento de diabetes mellitus.
TR200102977T2 (tr) Yeni tedavi yöntemi.
MY124695A (en) Novel composition and use.
MY155219A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
TR199903095T2 (tr) Diabetin roziglitazon ve insülin ile tedavisi.
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
DK1621207T3 (da) Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors
HK1041201A1 (zh) 貝塔激動劑和抗糖尿病製劑的配伍
AP2000001735A0 (en) Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor.
MY138246A (en) Treatment of diabetes with thiazolidione and sulphonylurea.
TR199903072T2 (tr) Diabetin tiazolidinedion ve alfa-glukosidaz ile tedavisi.
AR008025A1 (es) Combinación farmacéutica de una tiazolidindiona y un secretagogo de insulina
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
TR200000958T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı.
TR199801133T2 (tr) Tip II diyabetin tedavisi veya önlenmesi için nitrik oksit (NO) sentaz inhibitörü
CO5150158A1 (es) Tratamiento antidiabetico novedoso
ECSP982592A (es) Nuevo metodo de tratamiento v
ECSP982591A (es) Nuevo metodo de tratamiento iv
ECSP982541A (es) Nuevo metodo de tratamiento ii
ECSP982593A (es) Nuevo metodo de tratamiento vi